Common use of Authorization of Notes Clause in Contracts

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 aggregate principal amount of its 7.46% Senior Notes due 2007 (the "NOTES"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 120,000,000 aggregate principal amount of its 7.464.18% Senior Notes Notes, Series A, due 2007 September 30, 2026 (the "NOTES"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "“Series A Notes”) and

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 225,000,000 aggregate principal amount of its 7.46senior notes consisting of (i) $53,000,000 aggregate principal amount 5.65% Series A Senior Unsecured Notes due 2007 August 13, 2011 (the "NOTES"“Series A Notes”), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term ",

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 50,000,000 aggregate principal amount of its 7.464.42% Senior Notes Notes, Series F, due July 1, 2007 (the "NOTESSeries F Notes", such term to include any such notes issued in substitution therefore pursuant to Section 13), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term ";

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 40,000,000 aggregate principal amount of its 7.464.67% Senior Notes Notes, Series A, due 2007 January 15, 2021 (the "NOTES"“Series A Notes”), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term ",

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 50,000,000 aggregate principal amount of its 7.462.37% Senior Notes Notes, Series W, due 2007 January 27, 2027 (the "NOTES"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "“Series W Notes”) and

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 5,000,000 aggregate principal amount of its 7.465.23% Senior Notes Notes, Series 2015A, due 2007 October 1, 2045 (the "NOTES"“Notes”), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "“

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 75,000,000 aggregate principal amount of its 7.463.95% Senior Notes Notes, Series F, due 2007 October 25, 2023 (the "NOTES"“Notes,” such term to include any such notes issued in substitution therefor pursuant to Section 13), each such note to . The Notes shall be substantially in the form set out in Exhibit 1. As used herein, the term "“

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 15,000,000 aggregate principal amount of its 7.465.33% Senior Notes Notes, Series A, due 2007 December 10, 2043 (the "NOTES"“Notes,” such term to include any such notes issued in substitution therefor pursuant to Section 13), each such note to . The Notes shall be substantially in the form set out in Exhibit 1. As used herein, the term "“

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of Fifty Million Dollars ($60,000,000 50,000,000) aggregate principal amount of its 7.466.74% Senior Notes due 2007 May 1, 2013 (the "NOTESNotes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, ) and the term "

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 30,000,000 aggregate principal amount of its 7.468.25% Senior Notes due 2007 2024 (the "NOTES"“Notes”), each such note including the Notes to be substantially in the form set out in Exhibit 1issued and sold hereunder. As used herein, the term "“

Authorization of Notes. The Company has duly authorized will authorize the issue and sale sale, in two series, of $60,000,000 300,000,000 aggregate principal amount of its 7.46guaranteed senior notes, of which $150,000,000 aggregate principal amount shall be its 7.75% Series A Guaranteed Senior Notes due 2004 (the "Series A Notes") and $150,000,000 aggregate principal amount shall be its 7.87% Series B Guaranteed Senior Notes due 2007 (the "NOTESSeries B Notes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (i) $60,000,000 35,000,000 aggregate principal amount of its 7.467.54% Senior Notes Secured Notes, Series A, due 2007 May 21, 2009 (the "NOTESSeries A Notes") and (ii) $15,000,000 aggregate principal amount of its 7.76% Senior Secured Notes, Series B, due May 21, 2014 (the "Series B Notes" and together with the Series A Notes, the "Notes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the The term "

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 85,000,000 aggregate principal amount of its 7.46senior notes consisting of (i) $58,000,000 aggregate principal amount 4.15% Series D Senior Unsecured Notes due 2007 March 5, 2015 (the "NOTES"“Series D Notes” or the “Fixed Rate Notes”), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term ",

Authorization of Notes. The Company has duly authorized the issue and sale of up to $60,000,000 30,000,000 aggregate principal amount of its 7.469.00% Senior Notes due 2007 2033 (the "NOTES"“Notes”), each such note including the Notes to be substantially in the form set out in Exhibit 1issued and sold hereunder. As used herein, the term "“

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 25,000,000 aggregate principal amount of its 7.467.25% Senior Notes due 2007 2026 (the "NOTES"“Notes”), each such note including the Notes to be substantially in the form set out in Exhibit 1issued and sold hereunder. As used herein, the term "“

Authorization of Notes. The Company has duly authorized the issue and sale of up to $60,000,000 aggregate principal amount of its 7.469.25% Senior Notes due 2007 2028 (the "NOTES"“Notes”), each such note including the Notes to be substantially in the form set out in Exhibit 1issued and sold hereunder. As used herein, the term "“

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 50,000,000 aggregate principal amount of its 7.467.09% Series A Senior Notes due 2007 October 28, 2004 (the "NOTESSeries A Notes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "and

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (a) $60,000,000 50,000,000 aggregate principal amount of its 7.466.39% Senior Notes Notes, Series A, due April 1, 2007 (the "NOTESSeries A Notes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "; and

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of (i) $60,000,000 35,000,000 aggregate principal amount of its 7.467.03% Senior Notes Notes, Series A, due 2007 August 1, 2012 (the "NOTESSeries A Notes") and (ii) $15,000,000 aggregate principal amount of its 6.96% Senior Notes, Series B, due August 1, 2012 (the "Series B Notes", and together with the Series A Notes, the "Notes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the The term "

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 150,000,000 aggregate principal amount of its 7.464.60% Senior Notes due 2007 2008 (the "NOTESNotes"), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 145,000,000 aggregate principal amount of its 7.467.06% Senior Notes due 2007 December 18, 2008 (the "1998 NOTES"), . The terms "NOTE" and "NOTES" as used herein shall include each 1998 Note delivered pursuant to any provision of this Agreement and each Note delivered in substitution or exchange for any such note Note pursuant to any such provision. The form of each Note shall be substantially in the form set out in of Exhibit 1. As used herein, the term "1 hereto.

Authorization of Notes. The Company has duly authorized the issue and sale of $60,000,000 33,600,000 aggregate principal amount of its 7.467.50% Senior Notes due 2007 2027 (the "NOTES"“Notes”), each such note including the Notes to be substantially in the form set out in Exhibit 1issued and sold hereunder. As used herein, the term "“

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 126,000,000 aggregate principal amount of its 7.466.14% Senior Notes Notes, Series 2005-A, due 2007 August 1, 2010 (the "NOTES"“Notes”), each such note to be substantially in the form set out in Exhibit 1. As used herein, the term "“

Authorization of Notes. The Company has duly authorized will authorize the issue and sale of $60,000,000 135,000,000 aggregate principal amount of its 7.467.25% Senior Notes Notes, Series A, due 2007 (the "SERIES A NOTES") and $25,000,000 aggregate principal amount of its 7.30% Senior Notes, Series B, due 2009 (the "SERIES B NOTES" and, together with the Series A Notes, the "NOTES"), each such note notes to be substantially in the form repective forms set out in Exhibit 1Exhibits 1(a) and 1(b). As used herein, the term "